Carbapenem-resistant Klebsiella pneumoniae: Results of a laboratory surveillance program in an Italian general hospital (August 2014-January 2015): Surveillance of carbapenem-resistant Klebsiella pneumoniae

Advances in Experimental Medicine and Biology

Volumn 901, Issue , 2016, Pages 91-101

  Monari, Claudia ^a   Merlini, Luca ^a   Nardelli, Emanuela ^a   Cacioni, Maria ^b   Repetto, Antonella ^b   Mencacci, Antonella ^a   Vecchiarelli, Anna ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Carbapenemases; Colistin; CRKP; K. pneumoniae; KPC KP

Indexed keywords

CARBAPENEM; CARBAPENEMASE; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CHILD; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; GENERAL HOSPITAL; HUMAN; INFANT; ITALY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PHYLOGENY; YOUNG ADULT;

EID: 84990175298     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2015_5018     Document Type: Chapter

References (43)

1. Agodi A, Voulgari E, Barchitta M et al (2011) Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 49 (11):3986-3989. doi:10.1128/JCM.01242-11
2. Ah YM, Kim AJ, Lee JY (2014) Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44 (1):8-15. doi:10.1016/j.ijantimicag.2014.02.016
3. Ambretti S, Gaibani P, Caroli F et al (2010) A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. New Microbiol 33 (3):281-282
4. Bogdanovich T, Adams-Haduch JM, Tian GB et al (2011) Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 53(4):373-376. doi:10.1093/cid/cir401
5. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J (2007) Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 44(7):972-975. doi:10.1086/512370
6. Brolund A, Haeggman S, Edquist PJ et al (2010) The DiversiLab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods 83(2):224-230. doi:10.1016/j.mimet.2010.09.004
7. Canton R, Akova M, Carmeli Y et al (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18(5):413-431. doi:10.1111/j.1469-0691.2012.03821.x
8. Corbellini S, Caccuri F, Gelmi M et al (2014) Emergence of carbapenem-resistant Klebsiella pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. New Microbiol 37(2):177-183
9. European Centre for Disease Prevention Control (ECDC) (2013) Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf. Accessed 5 Oct 2015
10. European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2013) EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance:mechanisms/EUCAST_detection_of_resistance:mechanisms_v1.0_20131211.pdf. Accessed 1 Oct 2015
11. European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2015) Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. http://www.eucast.org. Accessed 8 Oct 2015
12. Falagas ME, Karageorgopoulos DE, Nordmann P (2011) Therapeutic options for infections wiThenterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol 6(6):653-666. doi:10.2217/fmb.11.49
13. Fontana C, Favaro M, Sarmati L et al (2010) Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 3:40. doi:10.1186/1756-0500-3-40
14. Giani T, D’Andrea MM, Pecile P et al (2009) Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 Carbapenemase. J Clin Microbiol 47(11):3793-3794. doi:10.1128/JCM.01773-09
15. Giani T, Pini B, Arena F et al (2013) Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 18(22) pii:20489
16. Giske CG, Gezelius L, Samuelsen O et al (2011) A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 17(4):552-556. doi:10.1111/j.1469-0691.2010.03294.x
17. Healy M, Huong J, Bittner T et al (2005) Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 43(1):199-207. doi:10.1128/JCM.43.1.199-207.2005
18. Higgins PG, Hujer AM, Hujer KM et al (2012a) Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolates. J Med Microbiol 61 (Pt 1):137-141. doi:10.1099/jmm.0.036046-0
19. Higgins PG, Janssen K, Fresen MM et al (2012b) Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing. J Clin Microbiol 50(11):3493-3500. doi:10.1128/JCM.01759-12
20. Hirsch EB, Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65(6):1119-1125. doi:10.1093/jac/dkq108
21. Kaase M, Szabados F, Wassill L et al (2012) Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J Clin Microbiol 50 (9):3115-3118. doi:10.1128/JCM.00991-12
22. Kelesidis T, Karageorgopoulos DE, Kelesidis I et al (2008) Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62(5):895-904. doi:10.1093/jac/dkn311
23. Kontopoulou K, Protonotariou E, Vasilakos K et al (2010) Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J Hosp Infect 76(1):70-73. doi:10.1016/j.jhin.2010.03.021
24. Ligozzi M, Fontana R, Aldegheri M et al (2010) Comparative evaluation of an automated repetitive-sequencebased PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak. J Clin Microbiol 48 (5):1690-1695. doi:10.1128/JCM.01528-09
25. Mencacci A, Monari C, Leli C et al (2013) Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 51 (2):603-606. doi:10.1128/JCM.01811-12
26. Mezzatesta ML, Gona F, Caio C et al (2011) Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin Microbiol Infect 17(9):1444-1447. doi:10.1111/j.1469-0691.2011.03572.x
27. Ministero della Salute (2013) Circolare: Sorveglianza e controllo delle infezioni da batteri produttori di carbapenemasi (CPE). [Circular letter: surveillance and control of infections due to carbapenemase-producing bacteria (CPE)]. DGPRE. 0004968-P-26/02/2013. http://www.salute.gov.it/portale/documentazione/p6_2_6.jsp?lingua=italiano&area=27&btnCerca=cerca&iPageNo=4. Accessed 14 Oct 2015
28. Monaco M, Giani T, Raffone M et al (2014) Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 19(42) pii:20939
29. Mouloudi E, Protonotariou E, Zagorianou A et al (2010) Bloodstream infections caused by metallo-betalactamase/Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31(12):1250-1256. doi:10.1086/657135
30. Munoz-Price LS, Poirel L, Bonomo RA et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13(9):785-796. doi:10.1016/S1473-3099(13)70190-7
31. Naas T, Nordmann P (1994) Analysis of a carbapenemhydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A 91(16):7693-7697
32. Nordmann P, Naas T, Poirel L (2011) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791-1798. doi:10.3201/eid1710.110655
33. Patel G, Bonomo RA (2011) Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 9(5):555-570. doi:10.1586/eri.11.28
34. Patel G, Huprikar S, Factor SH et al (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29 (12):1099-1106. doi:10.1086/592412
35. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657-686. doi:10.1128/CMR.18.4.657-686.2005
36. Sievert DM, Ricks P, Edwards JR et al (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34 (1):1-14. doi:10.1086/668770
37. Tumbarello M, Viale P, Viscoli C et al (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55(7):943-950. doi:10.1093/cid/cis588
38. Tzouvelekis LS, Markogiannakis A, Psichogiou M et al (2012) Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25(4):682-707. doi:10.1128/CMR.05035-11
39. Wayne PA (2014) Analysis and presentation of cumulative antimicrobial susceptibility test data; Approved Guideline-FourThedition. CLSI document M39-A4
40. Wayne PA (2015) Performance standards for antimicrobial susceptibility testing; Twenty-Fifth Informational Supplement; CLSI document M100-S25
41. World Health Organization (WHO) (2015) WHONET software. Version 5.6. http://www.who.int/drugresistance/whonetsoftware. Accessed 27 Mar 2015
42. Yigit H, Queenan AM, Anderson GJ et al (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45(4):1151-1161. doi:10.1128/AAC.45.4.1151-1161.2001
43. Zarkotou O, Pournaras S, Tselioti P et al (2011) Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17(12):1798-1803. doi:10.1111/j.1469-0691.2011.03514.x